Ohcanbohtosat - Marc Ferrante
- Čájehuvvo 1 - 20 / 125
- Sirdás čuovvovaš siidui
-
1
New biologics and small molecules in inflammatory bowel disease: an update Dahkki João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante
Almmustuhtton 2019Revisão -
2
-
3
New treatment options for inflammatory bowel diseases Dahkki Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche
Almmustuhtton 2018Revisão -
4
-
5
-
6
Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors Dahkki Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire
Almmustuhtton 2006Artigo -
7
-
8
-
9
-
10
-
11
-
12
-
13
Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis Dahkki Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire
Almmustuhtton 2020Artigo -
14
-
15
-
16
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease Dahkki Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Almmustuhtton 2018Artigo -
17
-
18
DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease Dahkki Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire
Almmustuhtton 2021Artigo -
19
Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression Dahkki Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire
Almmustuhtton 2022Artigo -
20
Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis Dahkki Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante
Almmustuhtton 2016Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Disease
Gastroenterology
Ulcerative colitis
Crohn's disease
Inflammatory bowel disease
Biology
Surgery
Infliximab
Immunology
Tumor necrosis factor alpha
Genetics
Adalimumab
Gene
Pathology
Physics
Biochemistry
Intensive care medicine
Vedolizumab
Chemotherapy
Colitis
Interquartile range
Retrospective cohort study
Cancer
Cell biology
Endoscopy
Odds ratio
Adverse effect
Confidence interval